Search Results - "Erban, John K."

Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer by Swain, Sandra M, Jeong, Jong-Hyeon, Geyer, Charles E, Costantino, Joseph P, Pajon, Eduardo R, Fehrenbacher, Louis, Atkins, James N, Polikoff, Jonathan, Vogel, Victor G, Erban, John K, Rastogi, Priya, Livingston, Robert B, Perez, Edith A, Mamounas, Eleftherios P, Land, Stephanie R, Ganz, Patricia A, Wolmark, Norman

“…In node-positive breast cancer, adjuvant doxorubicin plus cyclophosphamide followed by docetaxel was associated with significantly better disease-free survival…”
Get full text

Menstrual History and Quality-of-Life Outcomes in Women With Node-Positive Breast Cancer Treated With Adjuvant Therapy on the NSABP B-30 Trial by GANZ, Patricia A, LAND, Stephanie R, ERBAN, John K, LIVINGSTON, Robert B, PEREZ, Edith A, MAMOUNAS, Eleftherios P, WOLMARK, Norman, SWAIN, Sandra M, GEYER, Charles E, CECCHINI, Reena S, COSTANTINO, Joseph P, PAJON, Eduardo R, FEHRENBACHER, Louis, ATKINS, James N, POLIKOFF, Jonathan A, VOGEL, Victor G

“…Premenopausal women with breast cancer receiving adjuvant chemotherapy are at risk for amenorrhea. The National Surgical Adjuvant Breast and Bowel Project B-30…”
Get full text

Phase II Study of Neoadjuvant Docetaxel, Vinorelbine, and Trastuzumab Followed by Surgery and Adjuvant Doxorubicin Plus Cyclophosphamide in Women With Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancer by LIMENTANI, Steven A, BRUFSKY, Adam M, ERBAN, John K, JAHANZEB, Mohammed, LEWIS, Deborah

“…To evaluate the combination of docetaxel, vinorelbine, and trastuzumab as neoadjuvant therapy for human epidermal growth factor receptor 2…”
Get full text

Rapid Change in Mental Status in a Patient with Hypereosinophilia by Wang, Hanyin, Erban, John K.

“…We present the case of a 48-year-old female with acute onset altered mental status, who was found to have eosinophilia, elevated troponin, and embolic strokes…”
Get full text

Timing of Metastasis in Breast Cancer by Schwartz, Robert S, Erban, John K

“…Two studies provide some answers to the question of why cells in neoplastic lesions in the epithelial lining of ducts in the breast are more likely to…”
Get full text

3365 Treatment Interruptions and Early Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients by Mao, Daqin, Chang, Hong, Rodday, Angie Mae, Hachem, Hilal, Erban, John K., Freund, Karen, Parsons, Susan

“…OBJECTIVES/SPECIFIC AIMS: (1) To evaluate the association of patient and clinical factors with adherence to adjuvant hormone therapy (HT). (2) To examine the…”
Get full text

Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation by Narayanasami, Uma, Kanteti, Rajani, Morelli, Julie, Klekar, Alanna, Al-Olama, Asma, Keating, Claire, O'Connor, Colleen, Berkman, Eugene, Erban, John K., Sprague, Kellie A., Miller, Kenneth B., Schenkein, David P.

“…Peripheral blood cell (PBC) rescue has become the mainstay for autologous transplantation in patients with lymphoma, multiple myeloma, and solid tumors…”
Get full text

Hormone Replacement Therapy After Breast Cancer: A Systematic Review and Quantitative Assessment of Risk by COL, Nananda F, HIROTA, Linda K, ORR, Richard K, ERBAN, John K, WONG, John B, LAU, Joseph

“…Hormone replacement therapy (HRT) is typically withheld from women with breast cancer because of concern that it might increase the risk of recurrence. The…”
Get full text

Treatment interruption and discontinuation of hormonal therapy in hormone receptor-positive breast cancer patients by Mao, Daqin, Hachem, Hilal, Chang, Hong, Dima, Danai, Dower, Joshua, Wismer, Michael, Erban, John K., Freund, Karen M., Parsons, Susan K.

“…Purpose To investigate predictors of treatment interruption and early discontinuation of adjuvant hormonal therapy (HT) in a retrospective cohort of women with…”
Get full text

Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis by John, Preethi, Osani, Mikala C., Kodali, Abhigna, Buchsbaum, Rachel, Bannuru, Raveendhara R., Erban, John K.

“…There are several regimens recommended by the National Comprehensive Cancer Network (NCCN) for HER2-negative operable breast cancer. To our knowledge, no…”
Get full text

Efficacy and Effectiveness Too Trials: Clinical Trial Designs to Generate Evidence on Efficacy and on Effectiveness in Wide Practice by Selker, Harry P., Eichler, Hans‐Georg, Stockbridge, Norman L., McElwee, Newell E., Dere, Willard H., Cohen, Theodora, Erban, John K., Seyfert‐Margolis, Vicki L., Honig, Peter K., Kaitin, Kenneth I., Oye, Kenneth A., D'Agostino, Ralph B.

“…Efficacy trials, designed to gain regulatory marketing approval, evaluate drugs in optimally selected patients under advantageous conditions for relatively…”
Get full text

Evolution of modern breast cancer treatment: when less is more by Erban, John K

Get full text

Standardized activities for lay patient navigators in breast cancer care: Recommendations from a citywide implementation study by Freund, Karen M., Haas, Jennifer S., Lemon, Stephenie C., Burns White, Karen, Casanova, Nicole, Dominici, Laura S., Erban, John K., Freedman, Rachel A., James, Ted A., Ko, Naomi Y., LeClair, Amy M., Moy, Beverly, Parsons, Susan K., Battaglia, Tracy A.

“…Background There is a need for guidelines on patient navigation activities to promote both the quality of patient navigation and the standards of reimbursement…”
Get full text

Vitamin D supplementation for prevention of cancer: The D2d cancer outcomes (D2dCA) study by Chatterjee, Ranee, Erban, John K., Fuss, Paul, Dolor, Rowena, LeBlanc, Erin, Staten, Myrlene, Sheehan, Patricia, Pittas, Anastassios

“…Evidence on biological plausibility from mechanistic studies and data from observational studies suggest that vitamin D may be linked to risk of several types…”
Get full text

Breast cancer. Clinical practice guidelines in oncology by Carlson, Robert W, Allred, D Craig, Anderson, Benjamin O, Burstein, Harold J, Carter, W Bradford, Edge, Stephen B, Erban, John K, Farrar, William B, Goldstein, Lori J, Gradishar, William J, Hayes, Daniel F, Hudis, Clifford A, Jahanzeb, Mohammad, Kiel, Krystyna, Ljung, Britt-Marie, Marcom, P Kelly, Mayer, Ingrid A, McCormick, Beryl, Nabell, Lisle M, Pierce, Lori J, Reed, Elizabeth C, Smith, Mary Lou, Somlo, George, Theriault, Richard L, Topham, Neal S, Ward, John H, Winer, Eric P, Wolff, Antonio C

Get more information

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off by Upshaw, Jenica N., Ruthazer, Robin, Miller, Kathy D., Parsons, Susan K., Erban, John K., O’Neill, Anne M., Demissei, Biniyam, Sledge, George, Wagner, Lynne, Ky, Bonnie, Kent, David M.

“…Anthracycline agents can cause cardiotoxicity. We used multivariable risk prediction models to identify a subset of patients with breast cancer at high risk of…”
Get full text

Neoadjuvant therapy for treatment of breast cancer: the way forward, or simply a convenient option for patients? by Chatterjee, Abhishek, Erban, John K

“…The complexity of managing early stage breast cancer is well known. Optimal treatment is increasingly multidisciplinary and in the modern era informed by…”
Get full text

Development of Phase-Specific Breast Cancer Survivorship Care Plans by Boehm, Lauren, Weisberg, Tracey, Linendoll, Nadine, Damon, A. Circe, Erban, John K., Parsons, Susan K.

“…Phase-specific survivorship care plans (SCPs) have the potential to be powerful tools in providing individualized, comprehensive survivorship care,…”
Get full text

Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer by Dong, Jinghui, Esham, Kimberly S., Boehm, Lauren, Karim, Sabrina A., Lin, Mingqian, Mao, Daqin, Wang, Fengqing, Fein, Daniel, Wang, Hanyin, Studenmund, Christine, Weidner, Ruth Ann, Noubary, Farzad, Freund, Karen M., Erban, John K., Parsons, Susan K.

“…Evidence-based timeliness benchmarks have been established to assess quality of breast cancer care, as delays in treatment are associated with poor clinical…”
Get full text

Secondary pulmonary alveolar proteinosis in hematologic malignancies by Chaulagain, Chakra P, Pilichowska, Monika, Brinckerhoff, Laurence, Tabba, Maher, Erban, John K

“…Abstract Pulmonary alveolar proteinosis (PAP), characterized by deposition of intra-alveolar PAS positive protein and lipid rich material, is a rare cause of…”
Get full text